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Background: Mycoplasma synoviae is an avian pathogen that can lead to respiratory tract infections and arthritis in
chickens and turkeys, resulting in serious economic losses to the poultry industry. Enolase reportedly plays
important roles in several bacterial pathogens, but its role in M. synoviae has not been established. Therefore, in this
study, the enolase encoding gene (eno) of M. synoviae was amplified from strain WVU1853 and expressed in E. coli
BL21 cells. Then the enzymatic activity, immunogenicity and binding activity with chicken plasminogen (Plg) and
human fibronectin (Fn) was evaluated.
Results: We demonstrated that the recombinant M. synoviae enolase protein (rMsEno) can catalyze the conversion of
2-phosphoglycerate (2-PGA) to phosphoenolpyruvate (PEP), the Km and Vmax values of rMsEno were 1.1 × 10−3 M and
0.739 μmol/L/min, respectively. Western blot and immuno-electron microscopy analyses confirmed that enolase was
distributed on the surface and within the cytoplasm of M. synoviae cells. The binding assays demonstrated that
rMsEno was able to bind to chicken Plg and human Fn proteins. A complement-dependent mycoplasmacidal assay
demonstrated that rabbit anti–rMsEno serum had distinct mycoplasmacidal efficacy in the presence of complement,
which also confirmed that enolase was distributed on the surface of M. synoviae. An inhibition assay showed that the
adherence of M. synoviae to DF-1 cells pre-treated with Plg could be effectively inhibited by treatment with rabbit
anti-rMsEno serum.
Conclusion: These results reveal that M. synoviae enolase has good catalytic activity for conversion of 2-PGA to
PEP, and binding activity with chicken Plg and human Fn. Rabbit anti–rMsEno serum displayed an obvious
complement-dependent mycoplasmacidal effect and adherent inhibition effect. These results suggested that the
M. synoviae enolase plays an important role in M. synoviae metabolism, and could potentially impact M. synoviae
infection and immunity.
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Mycoplasma synoviae is a major poultry pathogen that
causes respiratory tract infection and arthritis in chic-
kens and turkeys worldwide [1]. M. synoviae infections
can lead to a range of diseases, from sub-clinical to
severe, cause serious economic losses to the poultry
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unless otherwise stated.poor hatchability, downgrading at slaughter, and increased
costs associated with control of the disease [2,3]. Once
chickens are infected by M. synoviae, they become more
vulnerable to other pathogens, such as Newcastle disease
virus, Infectious bursal disease virus, Infectious bronchitis
virus, Escherichia coli and M. meleagridis, thereby further
increasing economic losses [4-9]. Relevant research on
M. synoviae will establish a solid theoretical foundation
for further development of vaccines, diagnostic reagents,
and therapeutic drugs against M. synoviae infections.
Enolase (2-phospho-D-glycerate hydrolase) is an
enzyme which catalyzes the reversible interconversion of
2-phosphoglycerate (2-PGA) and phosphoenolpyruvate
(PEP). Studies have shown that enolase has many. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Analysis of rMsEno expression and purification using
SDS-PAGE followed by Coomassie blue staining. M: PageRuler™
Prestained Protein Ladder (SM0671, Fermentas). Lane 1: Total cellular
proteins of E. coli BL21 (DE3) cells transformed by pET-28a (+).
Lane 2: Total cellular proteins of E. coli BL21 (DE3) cells transformed
by pET-Eno. Lane 3: Supernatant of lysate of E. coli BL21 (DE3) cells
transformed by pET-Eno. Lane 4: Sediment of lysate of E. coli BL21
(DE3) cells transformed by pET-Eno. Lane 5: Purified recombinant
protein.
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activity with plasminogen (Plg) and fibronectin (Fn) and
it can act as a heat-shock protein [10]. Aside from its en-
zymatic activity, the binding activity of surface-exposed
enolase of microorganisms to Plg and Fn can assist
pathogenic microorganisms in adhesion to host cells and
dissemination within hosts, which potentially playing a
role in pathogenesis [11-14]. Moreover, as a protective
antigen, enolase is also an important potential candidate
antigen for vaccines against infection [15-17]. M. synoviae
enolase has also been confirmed to be a major immuno-
genic proteins and an extracellular protein [18-20], but
most features of M. synoviae enolase have not been
reported. Therefore, in the present study, the M. synoviae
eno gene was cloned and expressed, and then the expres-
sion product was characterized so as to elucidate its roles
in M. synoviae metabolism and pathogenesis.
Results
Cloning and expression of the M. synoviae eno gene
Three primer pairs (eno1F/eno1R, eno2F/eno2R, and
eno3F/eno3R) were used to PCR-amplify three fragments
of the eno gene from M. synoviae strain WVU 1853 and
then the full length of the eno gene was amplified using
primer pairs eno1F/eno3R. After digestion with the SacI/
XhoI restriction enzymes, the eno gene was cloned into
the pET-28a (+) vector. Sequence analysis indicated that
the eno gene was 1,359 bp in length and the tryptophan
codon (TGA) in the gene was successfully mutated to
TGG. The eno gene encoded a 452-amino-acid protein
with a theoretical molecular weight of approximately
49 kDa, which had a 99% sequence identity with that of
M. synoviae 53 (AE017245.1). It is also highly homologous
with those of other Mycoplasma species (70%–80%).
The recombinant pET-Eno plasmid was transformed
into E. coli BL21 (DE3) cells. Then the recombinant
rMsEno protein was expressed by induction with IPTG,
assessed by SDS-PAGE with Coomassie blue staining.
The results showed that more rMsEno was in the
supernatant than in the sediment, and rMsEno had an
apparent molecular weight of approximately 53 kDa
(Figure 1, lanes 2–4). Purified rMsEno had a single band
(Figure 1, lane 5).
Measurement of the enzymatic activity of the rMsEno
The enzymatic activity of purified rMsEno was higher
than that of rabbit muscle enolase in catalyzing the
conversion of 2-PGA to PEP at 30°C (Figure 2A). The
catalytic activity of rMsEno increased with the increase of
the 2-PGA concentration from 0.5 to 2.0 mM (Figure 2B).
Using the data mentioned above and applying double-
reciprocal Lineweaver-Burk plots, the Km and Vmax
values of rMsEno were determined to be 1.1 × 10−3 M and
0.739 μmol/L/min, respectively (Figure 2C).Subcellular localization of M. synoviae enolase
Rabbit anti-rMsEno serum was isolated and the ELISA
titer was determined as 1:15,000. To determine the distri-
bution of M. synoviae enolase, total cellular proteins,
membrane proteins and cytoplasmic proteins of M. syno-
viae were subjected to western blot analysis using rabbit
anti-rMsEno serum. Purified rMsEno and BSA were used
as positive and negative controls, respectively. The results
showed that the rabbit anti-rMsEno serum can bind to the
total cellular proteins, membrane and cytoplasmic proteins
of M. synoviae at approximately 49 kDa (Figure 3A, lanes
1, 3, and 4). The rMsEno antiserum can also bind to puri-
fied rMsEno at approximately 53 kDa (Figure 3A, lane 2)
and no specific binding strips was shown with BSA
(Figure 3A, lane 5). The results also indicated that M.
synoviae enolase existed in both membrane fractions and
cytoplasmic fractions of M. synoviae, but the content of
enolase in the cytoplasmic fractions is more than the
membrane fractions. The result was further confirmed by
immunoelectron microscopy with the colloid gold labeling
technique (Figure 3B). Non-immunized rabbit serum
showed no binding activity (Figure 3C).
Binding activity of rMsEno to chicken Plg and human Fn
Western blot analysis confirmed that both chicken Plg
and human Fn interacted with rMsEno with a binding
band of approximately 53 kDa (Figure 4A and 4B, lane 1).
Under similar conditions, BSA had no binding band
(Figures 4A and 4B, lane 2). The ELISA plate binding
assay showed that the rMsEno was able to bind to chicken
Plg and human Fn in a dose-dependent pattern. BSA
Figure 2 rMsEno enzymatic activity and its influence factors. (A) The enzymatic activity of rMsEno was determined by measuring the
conversion of 2-PGA to PEP. (B) The effect of substrate (2-PGA) concentration on the enzymatic activity of rMsEno. (C) Km and Vmax for rMsEno
were determined as 1.1 × 10−3 M and 0.793 μmol/L/min respectively, based on the Lineweaver–Burk plot (double-reciprocal plot).
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Fn (Figure 4C and 4D).
Adherence and inhibition assays
Adherence and inhibition assays have shown that the
M. synoviae WVU1853 strain can adhere to DF-1 cells
pre-treated with Plg (Figure 5A). And this adherence could
be inhibited by rabbit anti-rMsEno serum (Figure 5B).Figure 3 Determination of the localization of M. synoviae enolase. (A)
Lane 2: Purified rMsEno was used as a positive control. Lane 3: The cytosolic p
Lane 5: BSA was used as a negative control. (B) Immunoelectron microscopy
goat anti-rabbit IgG labeled with 12 nm diametral colloidal gold particles. (C)Non-immune rabbit serum showed no effect on the ad-
herence inhibition ofM. synoviae to DF-1 cells (Figure 5C).
Furthermore, immuno-fluorescence assay showed that no
fluorescence was detected when DF-1 cells were only
incubated with the goat anti-rabbit IgG (whole molecule)-
FITC (Figure 5D). Therefore, all these results have demon-
strated that M. synoviae enolase is an adhesion-related
protein.Western blot analysis. Lane 1: Total cellular proteins of M. synoviae.
roteins of M. synoviae. Lane 4: The membrane proteins of M. synoviae.
examination. Arrows pointed the M. synoviae enolase to be stained with
Non-immunized rabbit serum showed no any binding activity.
Figure 4 Binding assays. (A) Western blot analysis of the binding ability of rMsEno to chicken Plg. Lane 1: rMsEno; Lane 2: BSA. (B) Western blot
analysis of the binding ability of rMsEno to human Fn. Lane 1: rMsEno; Lane 2: BSA. (C) The binding ability of rMsEno to chicken plg. (D) The
binding ability of rMsEno to human Fn.
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As shown in Table 1, compared with the rabbit pre-
serum, the rabbit anti–rMsEno serum demonstrated an
obvious mycoplasmacidal activity (p < 0.01). The myco-
plasmacidal activity of the rabbit anti–rMsEno serum
was similar to that of rabbit anti-M. synoviae serum.
Discussion
Enolase is a multi-functional protein in both prokaryotes
and eukaryotes. Aside from its enzymatic activity, eno-
lase plays important roles in several biological and
pathophysiological processes: enolase serves as a Plg re-
ceptor on the surface of a variety of hematopoietic, epi-
thelial, and endothelial cells and plays a crucial role in
intravascular and pericellular fibrinolytic systems [10,21].
Enolase has been implicated in many infectious, auto-
immune, and inflammatory diseases [10,22-24]. More-
over, enolase has been identified as a protective antigen
in some pathogens [15-17]. Recent studies have shown
that enolase plays an important role in transcriptional
regulation and can also result in immune suppression
[25-27]. In the present study, the M. synoviae eno gene
was cloned and expressed in E. coli cells. SDS-PAGE
showed that more product of rMsEno expression wereFigure 5 Adherence and inhibition assays. (A) DF-1 cells pre-treated with
was inhibited by rabbit anti-rMsEno serum. (C) Treatment with non-immune ra
control of uninfected DF-1 cells showed no bacterial attachment when incubain the supernatant, which was convenient to study the
catalytic activity and other biological characteristics of
M. synoviae enolase. Subsequently, the expression pro-
ducts were purified and characterized. Enzymatic activity
analysis showed that the purified rMsEno could catalyze
the conversion of 2-PGA to PEP in reaction buffer with
10 mM MgCl2 at 30°C and pH 7.5.
The M. synoviae membrane and cytosolic proteins were
isolated and analyzed to determine the subcellular
localization of the M. synoviae enolase. By western blot
and immuno-electron microscopic analyses, we demon-
strated that M. synoviae enolase was found in the mem-
brane and cytoplasm portions, which is consistant with
the result reported previously [20], which might be more
conductive to perform its different functions. Lactobacilli
can rapidly modify their surface properties by translo-
cation of enolase to the cell surface or releasing into the
medium at different pH values [28]. Whether the M. syno-
viae enolase has similar effect will be validated in future
studies. Using a complement-dependent mycoplasmacidal
assay, we demonstrated that rabbit anti-rMsEno serum
displayed an obvious complement-dependent myco-
plasmacidal effect. It has been confirmed that Streptococ-
cus suis serotype 2 enolase was a protective antigen [16].Plg were infected with M. synoviae WVU 1853 strain. (B) The adherence
bbit serum showed no influence on the bacterial adherence. (D) Negative
ted with the goat anti-rabbit IgG (whole molecule)-FITC.
Table 1 Mycoplasmacidal activity of rabbit anti–rMsEno
serum




Rabbit anti-M. synoviae serum 13 94.09**
Rabbit anti-rMsEno serum 18 91.82**
Non-immunized rabbit serum 220 -
Blank control 280
aData were expressed as geomeans of three experiments, analyzed using the
Student’s t-test. **p < 0.01, compared to a negative control of non-immunized
rabbit serum.
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enolase may be an important surface-exposed antigen.
Further studies will be designed to investigate whether
M. synoviae enolase is a protective protein and could serve
as a vaccine candidate.
The study demonstrated that M. synoviae enolase can
bind to chicken Plg and human Fn, which is in accordance
with the studies on other species of Mycoplasma and
other microorganisms [14,29-34]. Moreover, the adher-
ence of M. synoviae to DF-1 cells can be effectively inhi-
bited by rabbit anti-rMsEno serum, which indicated that
M. synoviae enolase is an important adhesion-related fac-
tor. That was also confirmed by adherence and inhibition
assays of M. synoviae to the DF-1 cells pretreated with
Plg. Therefore, we reasoned that enolase plays important
roles in M. synoviae adherence, colonization, and invasion
to host cells, as reported in other pathogens [14,29].
Conclusion
In summary, the present study demonstrated that the
rMsEno displayed enolase activity by catalyzing the con-
version of 2-PGA to PEP. Moreover, the M. synoviae eno-
lase was identified as a surface-exposed protein, and rabbit
anti-rMsEno serum displayed an obvious complement-
dependent mycoplasmacidal effect. In addition, the present
study demonstrated that M. synoviae enolase could bind
to chicken Plg and human Fn, and rabbit anti-rMsEno
serum effectively inhibited adherence of M. synoviae to
DF-1 cells. Therefore, we concluded that M. synoviae
enolase plays an important role in M. synoviae metabol-
ism, and could potentially impact infection and immunity.




Restriction enzymes and T4 DNA ligase used in this study
were obtained from MBI Fermentas (Hanover, MD, USA).
PrimeSTAR® HS DNA polymerase was the product of
TaKaRa (Dalian, China). Complement sera (guinea pig
source) were obtained from the Control Institute of
Veterinary Bioproducts and Pharmaceuticals (CIVBP,Beijing, China). The reagents used for cell culture were
purchased from Gibco (Grand Island, NY, USA). All other
chemicals used in this study were analytical grade and
purchased from Sigma-Aldrich (St. Louis, MO, USA) or
Sangon Biotech (Shanghai, China).
Bacterial strains, cell line, plasmids and cultivation
conditions
M. synoviae strain WVU 1853 was obtained from the
Chinese Veterinary Culture Collection Center (Beijing,
China) and grown in Frey’s medium [35] at 37°C in an
atmosphere of 5% CO2. The strain was passed less than
five times in vitro. Escherichia coli strains DH5α and
BL21 (DE3) (Tiangen, Beijing, China) were cultured in
Luria-Bertani (LB) broth or on solid media containing
1.2% Noble agar [36] supplemented with 50 μg/mL of
kanamycin at 37°C. DF-1 cells, a continuous cell line of
chicken embryo fibroblasts, were obtained from the
American Type Culture Collection (Manassas, VA, USA)
and certified to be free of Mycoplasma contamination.
Cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum,
100 IU/mL of penicillin, and 100 μg/mL of streptomycin
at 37°C in an atmosphere of 5% CO2. The pET-28a (+)
expression vector was obtained from Novagen (Madison,
WI, USA).
Cloning and expression of the eno gene
M. synoviae genomic DNA was extracted from strain
WVU 1853 using the TIANamp Bacteria DNA Kit accor-
ding to the manufacturer’s protocol (Tiangen, Beijing,
China). According to the complete M. synoviae strain 53
genome sequence in the GenBank database (www.ncbi.
nlm.nih.gov/genbank/), there are two tryptophan codons
(TGA) in the coding DNA sequence (CDS) of M. synoviae
eno gene, which are stop codons in E. coli. Therefore,
three pairs of primers (eno1F/eno1R, eno2F/eno2R, and
eno3F/eno3R; Table 2) were designed and synthesized for
site-directed mutagenesis by overlap polymerase chain
reaction (PCR) to amplify the eno gene as previously
described [14]. The M. synoviae eno gene was amplified
using the eno1F/eno3R primer pair, which introduced the
SacI and XhoI restriction enzyme sites (underlined). A full
length codon-optimized eno gene was cloned into the
pET-28a (+) vector at the SacI/XhoI site. The amplifica-
tion of the recombinant plasmid pET-Eno was performed
using E. coli DH5α and then transformed into E. coli BL21
(DE3) cells. Expression of the recombinant M. synoviae
enolase protein (rMsEno) was induced by 1 mM isopropyl
β-D −1-thiogalactopyranoside (IPTG) for 4 h and puri-
fied using the Ni-NTA His-Bind® Resin kit (Novagen,
San Diego, USA). The purified expression products were
assessed by 10% sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) with Coomassie blue
Table 2 Primers used in this study
Primers Sequence (5′→ 3′) Localization (nt)c Size (bp)
eno1F CGAGAGCTCaATGTCAGCAATTAAAAAAATCC 1 202
eno1R CACCTTTTCCACCAAACbCAATTAG 202
eno2F CTAATTGGbTTTGGTGGAAAAGGTG 179 785
eno2R AAATCCAGCCbCAGTCGCTTT 963
eno3F AAAGCGACTGGbGCTGGATTT 944 399
eno3R CGGCTCGAGaTTATTTTTTAAGATTGTA 1342
aThe restriction sites of GAGCTC, CTCGAG for endonuclease SacI and XhoI were shown in italics.
bNucleotide substitutions were shown in boldface.
cLocalization was based on the nucleotide sequence of M. synoviae 53 eno gene (GeneID:3564671).
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(Thermo Scientific-Pierce, Rockford, IL, USA) and used
directly to measure enzymatic activity or stored at −20°C
for future use.
Determination of the enzymatic activity of rMsEno
The enzymatic activity of purified rMsEno was deter-
mined by measuring the enhancement of absorbance at
240 nm (OD240), which reflects the conversion of 2-PGA
to PEP at 30°C as previously described [37] with slight
modifications. Briefly, 1 mM 2-PGA was added to pre-
heated (30°C) reaction buffer (100 mM HEPES buffer,
7.7 mM KCl, 10 mM MgCl2, pH 7.5) followed by the
addition of 10 μg purified rMsEno to initiate the reac-
tion. The total volume of the reaction system was 2.0
mL and the reaction system was incubated at 30°C.
Absorbance at OD240 was determined using a spectro-
photometer at 1-min intervals for 30 min. Rabbit muscle
enolase (Sigma-Aldrich) was used as a positive control.
The enzymatic kinetics of the enolase were performed
with different 2-PGA concentrations (0.5, 1.5, and 2.0
mM). According to double-reciprocal Lineweaver–Burk
plots, the Michaelis constant (Km) and maximum reac-
tion velocity (Vmax) of rMsEno were determined.
Preparation of rabbit antisera against rMsEno and
M. synoviae whole cells
Rabbits were purchased from Shanghai Jia Gan Bio-
Technique Co. Ltd. (Shanghai, China) and housed in cages
with access to water and food ad libitum under biosafety
conditions. Animal experiments were carried out in
accordance with the Institutional Animal Care and Use
Committee (IACUC) guidelines set by Shanghai Veterinary
Research Institute, the Chinese Academy of Agricultural
Sciences (CAAS) and checked as Additional file 1. This
animal study protocol (12–02) was approved by the
IACUC of the Shanghai Veterinary Research Institute,
CAAS, China. To prepare polyclonal antibodies against
M. synoviae enolase and M. synoviae whole cells, two
New Zealand white rabbits (female; body weight, 2–3 kg)
were immunized four times at 2-week intervals bysubcutaneous injection with purified rMsEno protein (800
μg) or M. synoviae inactivated whole cells (1010 CFU,
inactivated with 0.4% formalin at 37°C for 16 h), mixed
with Imject® Alum adjuvant (Thermo Scientific-Pierce,
Waltham, MA, USA), respectively. Seven days after the
fourth immunization, blood samples were obtained from
the rabbits and centrifuged to obtain serum. The antibody
titers were measured by indirect ELISA, which the 96-well
ELISA plate was coated with 100 μL coating buffer (1.5 g/L
Na2CO3, 2.93 g/L NaHCO3, pH 9.6) containing 10 μg/mL
rMsEno or M. synoviae whole cells (107 CFU/well). Then
aliquots of the serum samples were placed in 1.5-mL
Eppendorf tubes and stored at −40°C for future use.
Subcellular localization of M. synoviae enolase
To determine the distribution of enolase in M. synoviae,
membrane proteins and cytoplasmic proteins of M.
synoviae were extracted using the ReadyPrep™ Protein
Extraction Kit (Membrane I) (Bio-Rad) according to the
manufacturer’s instructions, then equal volumes of
membrane proteins and cytoplasmic proteins were used
for western blot as follows: each protein sample were
loaded into each lane of an 10% polyacrylamide gel and
subjected to SDS-PAGE (80 V, 180 min). Subsequently,
the proteins were transferred to nitrocellulose membranes
(Whatman GmbH, Staufen, Germany) at 250 mA for 90
min. Then the membrane was blocked with 5% skim milk
for 3 h at room temperature. After washed three times
with PBST (PBS containing 0.05% Tween-20), the mem-
brane was incubated with rabbit anti-rMsEno serum
(dilution, 1:3,000) at 4°C overnight. The membrane was
washed three times and then incubated with goat anti-
rabbit immunoglobulin G (IgG) conjugated to horseradish
peroxidase (HRP; Sigma-Aldrich; dilution, 1:8,000) at
room temperature for 1.5 h. After three times washing,
the membrane was stained with enhanced chemilumines-
cence (ECL) reagent. Reactions were detected by exposure
on an X-ray film. The total protein of M. synoviae was
prepared by bacterial lysis buffer (Sangon, Shanghai,
China) according to the manufacturer’s instructions and
western blot analysis was performed as described above.
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and BSA (1.5 μg) as a negative control.
To further validate the distribution of enolase within the
cells, M. synoviae were grown to the mid-logarithmic
phase and centrifuged at 5,000 × g for 10 min at 4°C. After
washing three times using PBS (0.1 M, pH 7.2), the
samples were fixed with 4% paraformaldehyde and 0.5%
glutaraldehyde at room temperature for 1–2 h and rinsed
three times in PBS for 15 min each. After centrifugation,
the pellets were dehydrated with 70% ethanol twice for 30
min each, then 80% and 95% ethanol once for 15 min
each. Cells were collected by concentration and infiltrated
with 95% Ethanol: LR White (1:2) for 1 h, then 100% LR
White (Sigma-Aldrich) twice for 1 h and overnight
respectively. Embedment were performed with LR White
by exposure to UV light (365 nm) at −20°C. After blocked
with 0.05 M glycine solution for 10 min and 2% BSA for 1
h, the cells were incubated with rabbit anti-rMsEno serum
(1:1,000) at 4°C overnight. Each sample was rinsed six
times with a fixative for 10 min each times and re-
suspended in a 1:100 dilution of goat anti-rabbit IgG la-
beled with 10 nm colloidal gold particles (Sigma-Aldrich).
After 2 h incubation at room temperature, the cells were
rinsed five times with PBS at 5-min intervals, then the
samples were fixed with 2% glutaraldehyde at room
temperature for 10 min, rinsed with water, colored with
4.0% uranyl acetate for 15 min, rinsed with water again,
dried, and then observed by transmission electron micros-
copy. Non-immunized rabbit serum acts as a negative
control.
Binding activity of rMsEno to chicken Plg and human Fn
Western blot and ELISA plate binding assay were used to
determine the binding activity of rMsEno to chicken
Plg (Cell Sciences) and human Fn (Sigma-Aldrich). For
western blot analysis, 10 μg of purified rMsEno was
loaded into each lane on the 10% polyacrylamide gel and
electrophoresed. Bovine serum albumin (BSA; Sigma-
Aldrich) (10 μg) was used as a negative control. The pro-
teins were transferred to membranes, which were blocked
with 5% skim milk in PBST at room temperature for 3 h
as described above, then washed three times with PBST,
and incubated with 10 μg/mL of chicken Plg or human Fn
in PBST at 37°C for 2 h. After washing three times with
PBST, the membrane was incubated with rabbit anti-
chicken Plg monoclonal antibody (Cell Sciences; dilution,
1:3,000) or mouse anti-human Fn monoclonal antibody
(Sigma-Aldrich; dilution, 1:1,000) in PBST at room
temperature for 1.5 h, respectively. After washing, the
membrane was incubated with goat anti-rabbit IgG-HRP
(Sigma-Aldrich; dilution, 1:8,000) or goat anti-mouse
IgG-HRP (Sigma-Aldrich; dilution, 1:8,000) at room
temperature for 1.5 h. After washing three times with
PBST, the membrane was colored using an ECL kit(Amersham Pharmacia Biotech, Piscataway, NJ, USA)
according to the manufacturer’s instructions. Reactions
were detected by exposure on an X-ray film.
For the ELISA plate binding assay, the 96-well plates
were coated with purified rMsEno at 10 μg/well and incu-
bated at 4°C overnight. After being washed three times
with PBST, the wells were blocked with 5% skim milk in
PBST at 37°C for 2 h. The plates were three-times washed
again, and added with chicken Plg or human Fn (0, 1, 5,
10, 15, 20, 25, or 30 μg/mL in PBST) for a 2 h-incubation
at 37°C. After washing, the plates were incubated with
rabbit anti-chicken Plg IgG fraction pAb (100 μL per well;
Cell Sciences; dilution, 1:3,000) or mouse anti-human Fn
monoclonal antibody (100 μL per well; Sigma-Aldrich;
dilution, 1:3,000) at 37°C for 1.5 h. After washing, goat
anti-rabbit IgG-HRP or goat anti-mouse rabbit IgG-HRP
were added to wells (100 μL per well; Sigma-Aldrich;
dilution, 1:5,000) and the plates were incubated at 37°C
for 1 h. Finally, the color reaction was performed by ad-
ding soluble TMB substrate solution (TIANGEN, Beijing,
China) at 100 μL per well and incubated for 10 min
at room temperature. The reaction was stopped with
2 M H2SO4. Absorbance at OD450 was measured using a
spectrophotometer. Wells coated with BSA (10 μg/well)
were used as negative controls.
Adherence and inhibition assays
To validate the adherence function of M. synoviae eno-
lase to DF-1 cells, the monolayer DF-1 cells in a 35-mm
dish were washed three times with DMEM and incu-
bated with Plg (5 μg/mL) at 37°C in 5% CO2 for 2 h.
After washing, the cells were infected with M. synoviae
WVU 1853 strain at 200 multiplicity of infection (MOI)
for 2 h. The infected DF-1 cells were washed with PBS
to remove non-adherent Mycoplasma, and fixed with 4%
paraformaldehyde (PFA). The fixed cells were washed
with PBST and incubated with rabbit anti-M. synoviae
serum (1:1,000) at 37°C for 2 h. After three washes with
PBST, the cells were incubated with goat anti-rabbit IgG
(whole molecule)-FITC (Sigma-Aldrich; dilution, 1:500)
at 37°C for 1.5 h. The cell membranes were labeled with
500 μL of 10 μM 1,1′-dioctadecyl-3,3,3′,3′-tetramethylin-
docarbocyanine perchlorate (Beyotime, Jiangsu, China) at
room temperature for 10 min. After five washes with PBST,
the cell nuclei were labeled with 500 μL of 0.1 μg/mL of 4′,
6-diamidino-2-phenylindole (Beyotime) at room tempe-
rature for 10 min. Lastly, the cells were mounted and ob-
served using fluorescent microscopy (Ti-S; Nikon, Tokyo,
Japan) to evaluate the adherence. For the adherence
inhibition assay, the M. synoviae was incubated with
rabbit anti-rMsEno serum (dilution, 1:5) at 37°C for 30
min. After centrifugation at 10, 000 × g for 15 min, the M.
synoviae cell pellets were re-suspended and added to the
DF-1 cells to assess adherence as described above. All
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three times.
Complement dependent mycoplasmacidal assay
To determine the complement-dependent mycoplasmaci-
dal activity of rabbit anti–rMsEno serum, M. synoviae
were grown to mid-logarithmic phase, washed three times
with PBS by centrifugation at 5,000 × g for 10 min at 4°C,
and re-suspended in PBS at the final concentration of
6 × 103 CFU/mL. The reaction system was established as
follows: 160 μL of M. synoviae suspension and 60 μL of
rabbit anti-rMsEno serum (1:5) were gently mixed in
1.5-mL microcentrifuge tubes and incubated at 37°C for
30 min. Then, 30 μL of diluted complement (1:10) or PBS
were added, mixed, and incubated at 37°C for 1 h. The
reaction mixture (50 μL) was spread onto solid media in a
60-mm dish and incubated at 37°C in 5% CO2 for 7 days
to count the colonies. Rabbit anti-M. synoviae serum and
non-immunized rabbit serum were employed as positive
and negative controls, respectively. In addition, controls
for complement and PBS were included. All sera except
for complement used in the experiment were inactivated
at 56°C for 30 min. Three independent experiments were
performed in triplicate. The mycoplasmacidal coefficient
was calculated as follow: [(CFU of pre-serum treatment-
CFU of antiserum treatment)/(CFU of pre-serum treat-
ment)] × 100.
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